JARVIK HEART, Inc. Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial
8/14/2012 9:03:46 AM
More...
|
JARVIK HEART, Inc. Announces FDA Conditional Approval of Trial Using the Jarvik 2000® Heart for Destination Therapy
2/28/2012 6:59:10 AM
More...
|
Advanced Diamond Technologies Enters Agreement with JARVIK HEART, Inc. to Supply Diamond Coatings Engineered to Eliminate Blood Clotting in Heart Pumps
2/11/2009 6:30:54 AM
More...
|
JARVIK HEART, Inc. Release: Jarvik 2000 Heart Lives Up To Its Name
12/12/2005 2:20:30 PM
More...
|
FDA Approves JARVIK HEART, Inc. 2000 Pivotal Trial
10/19/2005 5:13:09 PM
More...
|
Jarvik Heart Release: Longest Surviving Artificial Heart Patient To Appear At The New York Academy Of Medicine
10/19/2005 5:13:06 PM
More...
|
JARVIK HEART, Inc. Announces World Record For Jarvik 2000 Heart
10/19/2005 5:11:09 PM
More...
|
JARVIK HEART, Inc. Is Awarded Major NIH Contract To Develop Heart Pump For Children
10/19/2005 5:11:03 PM
More...
|
JARVIK HEART, Inc. Release: Jarvik 2000 FlowMaker(R) CE Mark Approved In Europe
10/19/2005 5:10:23 PM
More...
|
JARVIK HEART, Inc. Receives Full FDA Approval To Conduct A Pivotal Trial Of The Jarvik 2000
10/19/2005 5:09:34 PM
More...
|